Detalles de la búsqueda
1.
Once-weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.
Diabetes Obes Metab
; 2024 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38679838
2.
Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
Diabetologia
; 66(1): 3-22, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36198829
3.
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Diabetes Obes Metab
; 25(2): 545-555, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263928
4.
A Roadmap to an Equitable Digital Diabetes Ecosystem.
Endocr Pract
; 29(3): 179-184, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36584818
5.
Roadmap to the Effective Use of Continuous Glucose Monitoring: Innovation, Investigation, and Implementation.
Diabetes Spectr
; 36(4): 327-336, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37982061
6.
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial.
Lancet
; 397(10270): 208-219, 2021 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453783
7.
Interindividual variability in average glucose-glycated haemoglobin relationship in type 1 diabetes and implications for clinical practice.
Diabetes Obes Metab
; 24(9): 1779-1787, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35546274
8.
Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.
Diabetes Obes Metab
; 23(11): 2572-2581, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34322967
9.
Beyond A1C-Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve.
Diabetes Spectr
; 34(2): 102-108, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34149250
10.
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
JAMA
; 325(22): 2262-2272, 2021 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34077499
11.
Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Diabetologia
; 63(2): 229-241, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31802144
12.
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Diabetologia
; 63(12): 2501-2520, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047169
13.
Advances in technology for management of type 1 diabetes.
Lancet
; 394(10205): 1265-1273, 2019 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31533908
14.
Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial.
Lancet
; 393(10176): 1138-1148, 2019 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808512
15.
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Pediatr Diabetes
; 21(8): 1375-1393, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047481
16.
Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial.
Lancet
; 392(10155): 1321-1329, 2018 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30292578
17.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
N Engl J Med
; 375(4): 311-22, 2016 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27295427
18.
Advanced Technology in the Management of Diabetes: Which Comes First-Continuous Glucose Monitor or Insulin Pump?
Curr Diab Rep
; 19(8): 50, 2019 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31250124
19.
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring.
Diabetes Obes Metab
; 21(8): 1906-1913, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993855
20.
Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial.
Age Ageing
; 48(6): 859-866, 2019 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31579904